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Purpose/Objective: To compare the quality of 3D versus 2D planning 
in postmastectomy patients in terms of target volume coverage and 
sparing of organs at risk. 
Materials and Methods: 27 postmastectomy patients, 16 with left and 
11 with right sided breast cancer. Clinical target volume was chest 
wall and supraclavicular fossa ± axilla. PTV1a consisted of chest wall, 
up to skin surface and PTV1b consisted of supraclavicular fossa ± axilla 
plus 1 cm margin; distance from skin surface was 0,5 cm. Deliniated 
organs at risk were both lungs, spinal cord and heart for left sided 
breast cancer. Total dose was 50 Gy in 25 fractions. For each patient 
2 plans were made: 3D and 2D plan. For 3D plan forward IMRT 
planning technique was used. Tangential fields were used for PTV1a 
and AP-PA opposed fields for PTV1b, all with 6MV photons. 2D plan 
was made using direct electron field (energy 9-12 MeV, depending on 
chest wallthickness) on PTV1a and combination of direct electron field 
(18 Mev) and direct photon field (6 MV) on PTV1b. For PTV1a bolus of 
0,5 cm was used. For 3D plans required PTV coverage with 95-107% of 
prescribed dose was at least 85%. Dose constraints for OAR were 
V20Gy< 35% for lung, Dmax <45 Gy for spinal cord and V20Gy< 10% and 
V40Gy< 5% for heart. Patients were placed on Med-Tec MT-350 with 
both hands above head, head in forward position. For planning XIO 
4.3.1 and 4.6.4 with fast-superposition and superposition algorhytm 
respectably for the photon beam calculation were used. Electron 
fields were calculated with pencil beam algorhytm. The CT slice 
thickness and calculation resolution of 0,2 cm was used. 
Statistical method: student t-test. 
Results 
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3D 88.8 
(3.5)* 
90.4 
(3.9) 
53.5 
(0.2) 
31.9 
(6.3) 
16.2 
(2.7) 
0.35 
(0.88) 
0.67 
(0.49)
7.6 
(1.9) 
3.5 
(1.1) 
5.0 
(1.2) 
36. 
(9.6) 
2D 83.1 
(7.2) 
61.2 
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73.5 
(3.3) 
31.0 
(13.3) 
15.2 
(5.4) 
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1.98 
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(3.5) 
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(0.5) 
5.6 
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33.2 
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p-
value 
<0.01 <10-6 <10-
6 
NS** NS NS <10-4 <0.03 <10-6 NS NS 
Right 
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3D 91.2 
(3.2) 
89.5 
(2.0) 
53.6 
(0.2) 
0.06 
(0.1) 
0.4 
(0.1) 
34.2 
(2.0) 
17.0 
(1.3) 
 39.7 
(5.8) 
2D 82.4 
(6.4) 
51.7 
(19.3) 
74.4 
(2.2) 
0.25 
(0.4) 
2.2 
(0.8) 
28.6 
(9.6) 
14.8 
(4.2) 
34.1 
(4.6) 
p-
value 
<0.01 <10-5 <10-
6 
<10-6 NS NS NS <0,03 
 
* median and standard deviation, ** not significant 
Statistically significant difference for left-sided breast cancer was 
observed in PTV1a and PTV1b coverage, MD on right lung, V20Gy and 
V40Gy on heart and Dmax. For right-sided breast cancer statistically 
significant difference was observed in PTV1a and PTV1b coverage, 
V20Gy on left lung, Dmax on spinal cord and Dmax.  
Conclusions: 3D planning provided significantly better PTV coverage 
and lower maximal doses, but without significant influence on doses 
on OAR (lungs and spinal cord) when compared to 2D planning. 
Nevertheless, higher doses on heart were observed with 3D planning, 
but within dose constraints. 
   
EP-1219   
Planning study of locally advanced ethmoid sinus cancer patient. 
H. Tanaka1, K. Nihei1, S. Kitou1, S. Kageyama1, T. Mitsuhashi1, K. 
Karasawa1 
1Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome 
Hospital, Radiation Oncology, Tokyo, Japan  
 
Purpose/Objective: The aim of this study is to compare the dose 
distributions of intensity-modulated radiotherapy (IMRT) plans and 
accuracy of patient setting between MHI TM-2000 (VERO), 
TomoTherapy HiArt System (TomoTherapy), and conventional linac 
(Clinac 21EX), all of which are installed in our institution. 
Materials and Methods: One patient with locally advanced ethmoid 
sinus cancer (T4aN0M0) treated by IMRT at our institution was 
evaluated in this planning study. The clinical target volume (CTV) was 
defined as gross tumor volume and right side nasal and paranasal 
sinus. The planning targetvolume (PTV) was defined as the CTV + 
three-dimensional margins of 5 mm. IMRT planning was implemented 
for 3 different treatment machines, including VERO,TomoTherapy, 
and Clinac 21EX, so as to achieve the similar optimal dose delivery to 
the target volumes with the same dose constraints for normal tissues. 
IMRT schedule consisted of 70Gy in 35fr. As the method of IMRT, 
segmental multi-leaf collimator (MLC) IMRT with 9 static ports, helical 
IMRT, and dynamic MLC IMRT with 9 static ports (2 non-coplaner ports 
and 7 coplaner ports), were adopted for VERO, TomoTherapy, and 
Clinic 21EX, respectively. As planning software, iPlan ver.4.5.1, 
TomoTherapy Planning Station 4.1.2, and Eclipse ver.10.0 were used 
for VERO, TomoTherapy, and Clinac 21EX, respectively. The dose-
volume parameters described below were calculated in each 
treatment machine: D2, D50 and D95 of the PTV and CTV; D2 of the 
optic nerves, chiasm, and eye balls; average dose of the Brain. As 
Modality of image guidance, Cone beam CT (KvCT), Cone beam CT 
(MvCT), and 2D EPID were used for VERO, TomoTherapy, and Clinac 
21EX, respectively. 
Results: The dose-volume parameters calculated in each treatment 
machine are shown in the table. 
 
  
Conclusions: The target volume coverage and the normal tissue doses 
in patients with locally advanced ethmoid sinus cancer were compared 
between the 3 treatment plans, using VERO, TomoTherapy, and Clinac 
21EX. All plans achieved acceptable dose delivery, but plan of Clinac 
21EX with 2D EPID may not achieve enough accuracy of patient 
setting.  
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Purpose/Objective: The beam attenuation impact on the planed dose 
distribution, due to the immobilization and repositioning systems 
(IRSs) used in radiotherapy, was studied to evaluate the need of IRS 
contouring.  
Materials and Methods: Three IRSs were selected for this study. In 
particular an uni-frame with PMMA support (UFP) (Tema Sinergie) was 
tested for 3DCRT 6 MV treatments, an uni-frame with carbon support 
(UFC) (Civco) was tested for head and neck IMTR 6 MV treatments and 
a Body Fix (BF) (3D Line) was tested for stereobody 6 and 15 MV 
treatments. The beam attenuation, when the beam axis intercepts the 
IRSs, was measured for 6 MV and 15 MV photon beams by ion-chamber 
and simulated by Eclipse (Varian) TPS to assess the TPS accuracy in 
modelling the IRS. Then 10 patients for each IRS were selected and 
two treatment plans were performed for each patient, with and 
without IRS contouring. The two plans were compared using dose 
volume histograms (DVH) and in particular evaluating the average 
dose to target variations. A method of transit in-vivo dosimetry (IVD) 
by EPID was adopted to verify that the IRS contouring was performed 
and gave the expected results in clinical routine. 
Results: The percentage of attenuations measured by ion-chamber for 
6 and 15 MV beams were 8.0% and 4.5% for UFP, 5.0% and 3.5% for UFC 
and 3% and 2% for BF respectively. These data were well reproduced 
by the TPS within ±1%. The mean percentage target dose variations 
obtained comparing the IRS contoured and not countered plans and 
averaged over the ten selected patients were 2.9 %, 1.1 % and 1.3 % 
for UFP, UFC and BF respectively. While the maximum percentage 
target dose variations were 6.5 %, 2.8 % and 2.5 % for UFP, UFC and BF 
respectively. IVD for patients with contoured IRS, performed in 
